Apollo Medical Holdings (ASTH) - Forward P/S Multiple

Corporate company logo of Astrana Corp (ASTH)

Astrana Health, Inc. (ASTH) relies on stable recurring payments from the value-based care system. This chart of the company's expected P/S confirms this resilience, where the value 0.20 captures the metric level. Efficiency is increasing through the cloud optimization of medical procurement. Meanwhile, the business is actively addressing physician turnover by attracting new specialists and retaining key IT personnel to develop the platform.

ASTH astranahealth.com: Market Cap to Projected Revenue in the range 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for Astrana Corp (ASTH)

- market price and analyst price targets:
Price Chart Astrana Health|ASTH - Fair Value Consensus
- market capitalization indicators:
Market Capitalization Astrana Corp|ASTH - Enterprise Value
- issuer book value statistics:
Net Assets per Single Share Astrana Health|ASTH - Accounting Capitalization|Market Capitalization to Book Value Ratio astranahealth.com|ASTH - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Astrana Health, Inc.|ASTH - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Astrana Health, Inc.|ASTH - Aggregate Debt Obligations|Debts to Book Capitalization Astrana Corp|ASTH - Long-Term Debt|Company Short-Term Debts Astrana Health|Quick Liquidity astranahealth.com
- business earnings and investment ratios data:
ASTH - Company Net Income|Future Profit Astrana Health, Inc.|ASTH - Market Price to Net Income Ratio|Forward P/E Multiple Apollo Medical Holdings|ASTH - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio Astrana Corp|ASTH - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Astrana Health|ASTH - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months astranahealth.com|ASTH - Earnings per share growth this year|Earnings growth forecast for next year Astrana Health, Inc.
- sales and revenue indicators:
ASTH - Company Sales|Company Future Sales Volume Astrana Health|ASTH - Price-to-Revenue Coefficient|Forward P/S Multiple Astrana Corp
Summary company analysis:Astrana Health ASTH
Manufactured products of Astrana Corp

Forward P/S evaluates market capitalization relative to expected revenue, revealing hidden overvaluation or undervaluation of the business. For Astrana Health, Inc. (ASTH), this ratio reflects market confidence in the monetization of AI platforms and predictive health analytics. By analyzing the projected P/S metric, an investor can determine the sustainability of the premium for technological leadership during periods of volatility. A decline in this indicator amid a stable R&D pipeline creates potential for a favorable entry point.

Competitor analysis

Price-to-Projected Revenue Ratio HCA Healthcare HCA|Forward Price to Sales THC|Fresenius Medical Care Corp - Forward P/S Multiple|SOLV - Forward P/S Multiple|Encompass Health (EHC) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue UHS|DVA (DaVita) - Forward P/S Multiple|Forward P/S Multiple RadNet Inc|Forward Price-to-Revenue Multiple OPCH (Option Care Health Inc)|SGRY (Surgery Partners Group) - Forward Price to Sales|Forward P/S Multiple PINC (Premier, Inc.)|Forward Price to Sales EYE|Progyny - Forward P/S Multiple|Market Cap to Future Revenue Ratio Ardent Health|SEM: Forward P/S Multiple|MEDNAX (MD) - Forward P/S Multiple|Price-to-Projected Revenue Ratio US Physical Therapy|Price-to-Projected Revenue Ratio PNTG|Forward Price-to-Revenue Multiple ORGO (Organogenesis)|Price to Expected Revenue Ratio NUTX|Forward P/S Multiple AUNA (Auna Health)|Forward Price to Sales SBC|EOLS: Forward Price-to-Revenue Multiple|Forward Price to Sales CYH (chs.net)|SKIN: Forward P/S Multiple|MDWD - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Biote Corp|Market Cap to Projected Revenue JYNT (The Joint)|Forward P/S Multiple DCGO|Forward Price-to-Revenue Multiple p3hp.org PIII|Gain Therapeutics - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio EUDA Health Holdings (EUDA)|Basel Medical Group Limited - Forward P/S Multiple|CLGN - Forward P/S Multiple|Cuprina Holdings (Cayman) Ltd (CUPR) - Price-to-Projected Revenue Ratio|CCM - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple AMS|MRM (MEDIROM Healthcare Group Inc.) - Price to Expected Revenue Ratio|Forward P/S Multiple ALBT|DHAI (DIH Group) - Forward Price to Sales|Longevity Health Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio NIVF (newgenivf.com)|ATIP - Price-to-Projected Revenue Ratio|Forward Price to Sales CMAX (CareMax Inc.)|KDLY: Forward P/S Multiple|Market Cap to Future Revenue Ratio ModivCare Corp (MODV)|NVOS (Novo Integrated Sciences) - Forward P/S Multiple|Forward P/S Multiple SunLink Health Systems, Inc|Forward Price-to-Revenue Multiple BACK (IMAC Holdings)